{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:50:13Z","timestamp":1777935013928,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019065","name":"Tianjin Science and Technology Program","doi-asserted-by":"publisher","award":["16YFZCSY00900"],"award-info":[{"award-number":["16YFZCSY00900"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC1001904"],"award-info":[{"award-number":["2017YFC1001904"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.biopha.2020.110235","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T11:53:46Z","timestamp":1590234826000},"page":"110235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The synergistic effect of NELL1 and adipose-derived stem cells on promoting bone formation in osteogenesis imperfecta treatment"],"prefix":"10.1016","volume":"128","author":[{"given":"Yi","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyan","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaci","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqing","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2020.110235_bib0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.berh.2007.12.012","article-title":"Osteogenesis imperfecta","volume":"22","author":"Glorieux","year":"2008","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110235_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/humu.20429","article-title":"Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans","volume":"28","author":"Marini","year":"2007","journal-title":"Hum. Mutat."},{"issue":"6","key":"10.1016\/j.biopha.2020.110235_bib0015","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S8756-3282(00)00269-6","article-title":"Static and dynamic bone histomorphometry in children with osteogenesis imperfecta","volume":"26","author":"Rauch","year":"2000","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.biopha.2020.110235_bib0020","first-page":"77","article-title":"Modern approach to children with osteogenesis imperfecta","volume":"12","author":"Zeitlin","year":"2003","journal-title":"J. Pediatr. Orthop. B"},{"issue":"6","key":"10.1016\/j.biopha.2020.110235_bib0025","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1302\/0301-620X.80B6.0800999","article-title":"Surgical stabilisation of the lower limb in osteogenesis imperfecta using the Sheffield Telescopic Intramedullary Rod System","volume":"80","author":"Wilkinson","year":"1998","journal-title":"J. Bone Joint Surg. Br."},{"issue":"9418","key":"10.1016\/j.biopha.2020.110235_bib0030","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta","volume":"363","author":"Rauch","year":"2004","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.biopha.2020.110235_bib0035","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.biopha.2020.110235_bib0040","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jbmr.11","article-title":"Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial","volume":"25","author":"Schwartz","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.biopha.2020.110235_bib0045","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00223-012-9588-3","article-title":"Recent advances in osteogenesis imperfecta","volume":"90","author":"Cundy","year":"2012","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.biopha.2020.110235_bib0050","first-page":"367","article-title":"Current and emerging treatments for the management of osteogenesis imperfecta","volume":"6","author":"Monti","year":"2010","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.biopha.2020.110235_bib0055","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","volume":"10","author":"Dwan","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2020.110235_bib0060","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1530\/EJE-10-0208","article-title":"GH in combination with bisphosphonate treatment in osteogenesis imperfecta","volume":"163","author":"Antoniazzi","year":"2010","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110235_bib0065","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1359\/JBMR.051207","article-title":"Cyclical intravenous pamidronate treatment affects metaphyseal modeling in growing patients with osteogenesis imperfecta","volume":"21","author":"Land","year":"2006","journal-title":"J. Bone Miner. Res."},{"issue":"11","key":"10.1016\/j.biopha.2020.110235_bib0070","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1359\/JBMR.040814","article-title":"Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate","volume":"19","author":"Munns","year":"2004","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.biopha.2020.110235_bib0075","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S8756-3282(02)00974-2","article-title":"Alendronate affects long bone length and growth plate morphology in the oim mouse model for Osteogenesis Imperfecta","volume":"32","author":"Evans","year":"2003","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.biopha.2020.110235_bib0080","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1359\/jbmr.081238","article-title":"Alendronate treatment of the brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but decreases predicted material properties and has detrimental effects on osteoblasts and bone formation","volume":"24","author":"Uveges","year":"2009","journal-title":"J. Bone Miner. Res."},{"issue":"13","key":"10.1016\/j.biopha.2020.110235_bib0085","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1073\/pnas.132252399","article-title":"Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone","volume":"99","author":"Horwitz","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.biopha.2020.110235_bib0090","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5966\/sctm.2013-0090","article-title":"Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experience","volume":"3","author":"Gotherstrom","year":"2014","journal-title":"Stem Cells Transl. Med."},{"issue":"4","key":"10.1016\/j.biopha.2020.110235_bib0095","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.bbrc.2007.02.165","article-title":"Bone regeneration by implantation of adipose-derived stromal cells expressing BMP-2","volume":"356","author":"Li","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2020.110235_bib0100","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12015-010-9193-7","article-title":"The potential of adipose stem cells in regenerative medicine","volume":"7","author":"Lindroos","year":"2011","journal-title":"Stem Cell Rev Rep"},{"issue":"2","key":"10.1016\/j.biopha.2020.110235_bib0105","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1159\/000456885","article-title":"NEL-like Molecule-1 (Nell1) is regulated by bone morphogenetic protein 9 (BMP9) and potentiates BMP9-Induced osteogenic differentiation at the expense of adipogenesis in mesenchymal stem cells","volume":"41","author":"Wang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2020.110235_bib0110","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.1038\/ncomms8362","article-title":"NELL-1 in the treatment of osteoporotic bone loss","volume":"6","author":"James","year":"2015","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.biopha.2020.110235_bib0115","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/abbs\/gms070","article-title":"Lentiviral-mediated gene transfer into human adipose-derived stem cells: role of NELL1 versus BMP2 in osteogenesis and adipogenesis in vitro","volume":"44","author":"Liu","year":"2012","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.biopha.2020.110235_bib0120","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bone.2019.07.021","article-title":"A novel transgenic murine model with persistently brittle bones simulating osteogenesis imperfecta type I","volume":"127","author":"Liu","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.biopha.2020.110235_bib0125","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/1876893800901010054","article-title":"Effects of culturing on the stability of the putative murine adipose derived stem cells markers","volume":"1","author":"Maddox","year":"2009","journal-title":"Open Stem Cell J."},{"issue":"3\u20134","key":"10.1016\/j.biopha.2020.110235_bib0130","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1089\/ten.tea.2012.0042","article-title":"NELL-1 injection maintains long-bone quantity and quality in an ovariectomy-induced osteoporotic senile rat model","volume":"19","author":"Kwak","year":"2013","journal-title":"Tissue Eng. Part A"},{"issue":"5","key":"10.1016\/j.biopha.2020.110235_bib0135","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","article-title":"Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation","volume":"89","author":"Ducy","year":"1997","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biopha.2020.110235_bib0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18010159","article-title":"Osteocalcin mediates biomineralization during osteogenic maturation in human mesenchymal stromal cells","volume":"18","author":"Tsao","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"8 Pt 2","key":"10.1016\/j.biopha.2020.110235_bib0145","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/clinchem\/45.8.1359","article-title":"Clinical utility of biochemical markers of bone remodeling","volume":"45","author":"Watts","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.biopha.2020.110235_bib0150","doi-asserted-by":"crossref","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","article-title":"Osteogenesis imperfecta","volume":"3","author":"Marini","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"12","key":"10.1016\/j.biopha.2020.110235_bib0155","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0003-9993(98)90426-9","article-title":"Osteogenesis imperfecta in childhood: treatment strategies","volume":"79","author":"Engelbert","year":"1998","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"6","key":"10.1016\/j.biopha.2020.110235_bib0160","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00198-008-0759-z","article-title":"The relation between bisphosphonate use and non-union of fractures of the humerus in older adults","volume":"20","author":"Solomon","year":"2009","journal-title":"Osteoporos. Int."},{"issue":"9","key":"10.1016\/j.biopha.2020.110235_bib0165","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1007\/s00264-013-2249-y","article-title":"Local transplantation is an effective method for cell delivery in the osteogenesis imperfecta murine model","volume":"38","author":"Pauley","year":"2014","journal-title":"Int. Orthop."},{"issue":"9","key":"10.1016\/j.biopha.2020.110235_bib0170","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1182\/blood-2011-12-400085","article-title":"Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms","volume":"120","author":"Otsuru","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.biopha.2020.110235_bib0175","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92573","article-title":"NELL-1 induces Sca-1+ mesenchymal progenitor cell expansion in models of bone maintenance and repair","volume":"2","author":"James","year":"2017","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.biopha.2020.110235_bib0180","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2353\/ajpath.2006.051210","article-title":"Nell-1-induced bone regeneration in calvarial defects","volume":"169","author":"Aghaloo","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110235_bib0185","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1172\/JCI15375","article-title":"Craniosynostosis in transgenic mice overexpressing Nell-1","volume":"110","author":"Zhang","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.biopha.2020.110235_bib0190","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1089\/ten.tea.2009.0384","article-title":"Effect of Nell-1 delivery on chondrocyte proliferation and cartilaginous extracellular matrix deposition","volume":"16","author":"Lee","year":"2010","journal-title":"Tissue Eng. Part A"},{"issue":"2","key":"10.1016\/j.biopha.2020.110235_bib0195","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ajpath.2015.10.011","article-title":"Novel wnt regulator NEL-Like Molecule-1 antagonizes adipogenesis and augments osteogenesis induced by bone morphogenetic protein 2","volume":"186","author":"Shen","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"3\u20134","key":"10.1016\/j.biopha.2020.110235_bib0200","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/ten.tea.2011.0142","article-title":"NELL-1 promotes cartilage regeneration in an in vivo rabbit model","volume":"18","author":"Siu","year":"2012","journal-title":"Tissue Eng. Part A"},{"issue":"1","key":"10.1016\/j.biopha.2020.110235_bib0205","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00223-011-9493-1","article-title":"Maxillary sinus floor elevation using BMP-2 and Nell-1 gene-modified bone marrow stromal cells and TCP in rabbits","volume":"89","author":"Xia","year":"2011","journal-title":"Calcif. Tissue Int."},{"issue":"5","key":"10.1016\/j.biopha.2020.110235_bib0210","doi-asserted-by":"crossref","first-page":"e3087","DOI":"10.1002\/jgm.3087","article-title":"Improved biosafety of a lentiviral vector by reducing cellular gene activation","volume":"21","author":"Song","year":"2019","journal-title":"J. Gene Med."},{"key":"10.1016\/j.biopha.2020.110235_bib0215","series-title":"Curr Protoc Mol Biol","article-title":"Overview of the HIV-1 lentiviral vector system","author":"Ramezani","year":"2002"},{"issue":"4","key":"10.1016\/j.biopha.2020.110235_bib0220","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/mt.2009.1","article-title":"Optimized lentiviral vector design improves titer and transgene expression of vectors containing the chicken beta-globin locus HS4 insulator element","volume":"17","author":"Hanawa","year":"2009","journal-title":"Mol. Ther."},{"issue":"12","key":"10.1016\/j.biopha.2020.110235_bib0225","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1634\/stemcells.2008-0258","article-title":"Combinatorial incorporation of enhancer-blocking components of the chicken beta-globin 5\u2019HS4 and human T-cell receptor alpha\/delta BEAD-1 insulators in self-inactivating retroviral vectors reduces their genotoxic potential","volume":"26","author":"Ramezani","year":"2008","journal-title":"Stem Cells"},{"issue":"7320","key":"10.1016\/j.biopha.2020.110235_bib0230","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature09523","article-title":"The CRISPR\/Cas bacterial immune system cleaves bacteriophage and plasmid DNA","volume":"468","author":"Garneau","year":"2010","journal-title":"Nature"},{"issue":"6096","key":"10.1016\/j.biopha.2020.110235_bib0235","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.biopha.2020.110235_bib0240","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"issue":"9","key":"10.1016\/j.biopha.2020.110235_bib0245","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.2673","article-title":"High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity","volume":"31","author":"Pattanayak","year":"2013","journal-title":"Nat. Biotechnol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220304273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220304273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:42:05Z","timestamp":1777689725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220304273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":49,"alternative-id":["S0753332220304273"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110235","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The synergistic effect of NELL1 and adipose-derived stem cells on promoting bone formation in osteogenesis imperfecta treatment","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110235"}}